Patient Leaflet Updated 07-Oct-2024 | AbbVie Ltd
Skyrizi 150 mg solution for injection in pre-filled syringe (Great Britain)
Skyrizi 150 mg solution for injection in pre-filled syringe
risankizumab
1. What Skyrizi is and what it is used for
2. What you need to know before you use Skyrizi
3. How to use Skyrizi
4. Possible side effects
5. How to store Skyrizi
6. Contents of the pack and other information
7. Instructions for use
Skyrizi contains the active substance risankizumab.
Skyrizi is used to treat the following inflammatory diseases:
This medicine works by stopping a protein in the body called ‘IL-23’, which causes inflammation.
Plaque psoriasis
Skyrizi is used to treat adults with moderate to severe plaque psoriasis. Skyrizi reduces inflammation and can therefore help reduce symptoms of plaque psoriasis such as burning, itching, pain, redness, and scaling.
Psoriatic arthritis
Skyrizi is used to treat adults with psoriatic arthritis. Psoriatic arthritis is a disease that causes inflamed joints and psoriasis. If you have active psoriatic arthritis, you may first be given other medicines. If these medicines do not work well enough, you will be given Skyrizi either alone or in combination with other medicines to treat your psoriatic arthritis.
Skyrizi reduces inflammation and can therefore help to reduce pain, stiffness, and swelling in and around your joints, pain and stiffness in your spine, psoriatic skin rash, psoriatic nail damage, and it may slow down damage to the bone and cartilage in your joints. These effects can ease your normal daily activities, reduce tiredness, and improve your quality of life.
Talk to your doctor, pharmacist or nurse before and during the use of Skyrizi:
It is important to keep a record of the batch number of your Skyrizi.
Every time you get a new pack of Skyrizi, note down the date and the batch number (which is on the packaging after “Lot”) and keep this information in a safe place.
Allergic reactions
Tell your doctor or seek medical help immediately if you notice any signs of an allergic reaction while you are taking Skyrizi such as:
Skyrizi is not recommended for children and adolescents under 18 years of age. This is because Skyrizi has not been studied in this age group.
Tell your doctor, pharmacist or nurse:
If you are not sure, talk to your doctor, pharmacist or nurse before and during the use of Skyrizi.
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine. This is because it is not known how this medicine will affect the baby.
If you are a woman who can become pregnant, you should use contraception while using this medicine and for at least 21 weeks after your last dose of Skyrizi.
If you are breast-feeding or are planning to breast-feed, talk to your doctor before using this medicine.
Skyrizi is not likely to affect your driving and use of machines.
This medicine contains less than 1 mmol sodium (23 mg) per pre-filled syringe, that is to say essentially ‘sodium-free’.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
This medicine is given as an injection under your skin (called a ‘subcutaneous injection’).
Each dose is 150 mg given as a single injection. After the first dose, you will have the next dose 4 weeks later, and then every 12 weeks.
You and your doctor, pharmacist or nurse will decide if you should inject this medicine yourself. Do not inject yourself with this medicine unless you have been trained by your doctor, pharmacist or nurse. A caregiver may also give your injection after they have been trained.
Read section 7 ‘Instructions for use’ at the end of this leaflet before injecting Skyrizi yourself.
If you have used more Skyrizi than you should or the dose has been given sooner than prescribed, talk to your doctor.
If you forget to use Skyrizi, inject a dose as soon as you remember. Talk to your doctor if you are not sure what to do.
Do not stop using Skyrizi without talking to your doctor first. If you stop treatment, your symptoms may come back.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Talk to your doctor or get medical help immediately if you have symptoms of a serious infection such as:
Your doctor will decide if you can keep using Skyrizi.
Tell your doctor, pharmacist or nurse if you get any of the following side effects
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the syringe label and outer carton after ‘EXP’.
Store in a refrigerator (2°C - 8°C). Do not freeze.
Keep the pre-filled syringe in the original carton in order to protect from light.
If needed, you may also store the pre-filled syringe out of the refrigerator (up to a maximum of 25°C) for up to 24 hours in the original carton to protect from light.
Do not use this medicine if the liquid is cloudy or contains flakes or large particles.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Skyrizi is a clear and colourless to yellow liquid in a pre-filled syringe with needle guard. The liquid may contain tiny white or clear particles.
Each pack contains 1 pre-filled syringe.
This leaflet was last revised in 08/2024
To listen to or request a copy of this leaflet in Braille, large print or audio, please contact the Marketing Authorisation Holder.
Please read all of section 7 before using Skyrizi
For a more comfortable injection: Take the carton out of the refrigerator and leave it at room temperature, out of direct sunlight, for 15 to 30 minutes before injecting.
STEP 1
Remove the pre-filled syringe from the cardboard sleeve by holding the finger grip.
Place the following items on a clean, flat surface:
Wash and dry your hands.
STEP 2
Choose from these 3 areas to inject:
Before the injection, wipe where you will inject in a circular motion with an alcohol pad.
Do not inject into areas affected by psoriasis
STEP 3
Hold the syringe with the covered needle pointing down, as shown.
Check the liquid in the syringe.
Do not use if the liquid is cloudy or contains flakes or large particles
STEP 4
Removing the needle cover:
Do not touch the needle with your fingers or let the needle touch anything
STEP 5
Hold the body of the syringe in one hand between the thumb and index finger, like you would a pencil.
Gently pinch the area of cleaned skin with your other hand and hold it firmly.
Insert the needle all the way into the skin at about a 45-degree angle using a quick, short movement. Keep the syringe steady at the same angle.
STEP 6
Slowly push the plunger rod all the way in until all of the liquid is injected.
Pull the needle out of the skin while keeping the syringe at the same angle.
Slowly take your thumb off the plunger rod. The needle will then be covered by the needle guard.
Press a cotton ball or gauze pad where you have injected and hold for 10 seconds.
Do not rub the skin where you have injected. You may have slight bleeding from where you injected. This is normal.
STEP 7
Throw away the used syringe in a special disposal container straight after use.
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
www.abbviemedinfo.com
+44 (0)1628 561 092
+44 (0)1628 561 092
www.abbvie.co.uk
0800 783 1699